Noxafil 300mg (18mg/ml)
Noxafil 300mg (18mg/ml) is a medicine authorised by Swissmedic under authorisation number 65172. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 December 2015 and the authorisation is valid without a time limit. ATC code J02AC04 places the medicine in the group Antimycotics for systemic use.
| Authorisation number | 65172 |
|---|---|
| Name | Noxafil 300mg (18mg/ml) |
| Full name | Noxafil 300mg (18mg/ml), Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | MSD Merck Sharp & Dohme AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | J02AC04 |
| First authorisation | 16 December 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Noxafil 300mg (18mg/ml), Konzentrat zur Herstellung einer Infusionslösung | B | 16 December 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J02AC04 | 08.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Noxafil 300mg (18mg/ml) authorised in Switzerland?
Yes. Noxafil 300mg (18mg/ml) is authorised by Swissmedic under authorisation number 65172, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Noxafil 300mg (18mg/ml) have?
Noxafil 300mg (18mg/ml) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Noxafil 300mg (18mg/ml)?
The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.